K222143 is an FDA 510(k) clearance for the APIS (R), VERIS (TM). Classified as Dressing, Wound, Drug (product code FRO).
Submitted by Sweetbio, Inc. (Memphis, US). The FDA issued a Cleared decision on October 13, 2023 after a review of 450 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.
View all Sweetbio, Inc. devices